Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 917 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Happy New Year From Our Team January 4, 2021 Ahead of ESMO Immuno-Oncology Congress 2025: topics at a glance December 4, 2025 Intercontinental Asian Study Compiles the Relative Incidence of non-Hodgkin T-cell Lymphoma... November 21, 2020 Child Cancer Patient And His Dad Have A Little Fun When... October 3, 2019 Load more HOT NEWS Study Links Mental Health Treatment to Improved Cancer Survival The rise of the ‘long-waiter’ – why cancer waiting times are... Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended... FDA Approves Pralsetinib for Lung Cancer with RET Gene Fusions
